Total Payments
$2,909
2024 Payments
$403.79
Companies
33
Transactions
223
Medicare Patients
3,827
Medicare Billing
$229,659
Payment Breakdown by Category
Food & Beverage$2,909 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,909 | 223 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $935.51 | 82 | $0 (2024) |
| ABBVIE INC. | $489.82 | 38 | $0 (2024) |
| Novo Nordisk Inc | $243.31 | 17 | $0 (2024) |
| Merck Sharp & Dohme LLC | $104.81 | 8 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $98.10 | 7 | $0 (2022) |
| Allergan, Inc. | $90.56 | 6 | $0 (2020) |
| PFIZER INC. | $90.39 | 7 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $78.77 | 4 | $0 (2023) |
| Lilly USA, LLC | $78.07 | 6 | $0 (2024) |
| Daiichi Sankyo Inc. | $73.78 | 5 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $403.79 | 27 | ABBVIE INC. ($143.90) |
| 2023 | $479.70 | 36 | AbbVie Inc. ($186.13) |
| 2022 | $498.41 | 41 | Amgen Inc. ($135.60) |
| 2021 | $537.89 | 44 | Amgen Inc. ($135.90) |
| 2020 | $333.54 | 26 | Amgen Inc. ($180.47) |
| 2019 | $86.77 | 6 | Amgen Inc. ($42.46) |
| 2018 | $241.32 | 18 | Amgen Inc. ($39.47) |
| 2017 | $327.09 | 25 | Amgen Inc. ($110.33) |
All Payment Transactions
223 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: PSYCHIATRY | ||||||
| 12/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Diabetes | ||||||
| 11/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $12.01 | General |
| Category: Bone Health | ||||||
| 09/27/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.27 | General |
| Category: NEUROSCIENCE | ||||||
| 09/20/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $11.56 | General |
| Category: Bone Health | ||||||
| 09/20/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $11.16 | General |
| Category: Inflammation | ||||||
| 09/16/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: Biological | ||||||
| 08/21/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: Inflammation | ||||||
| 08/19/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: Bone Health | ||||||
| 07/24/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: Inflammation | ||||||
| 07/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: NEUROSCIENCE | ||||||
| 06/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.74 | General |
| Category: NEUROSCIENCE | ||||||
| 06/03/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: Bone Health | ||||||
| 05/30/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE | Food and Beverage | In-kind items and services | $34.65 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: Cardio-renal | ||||||
| 05/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.76 | General |
| Category: NEUROSCIENCE | ||||||
| 05/06/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $11.59 | General |
| Category: Bone Health | ||||||
| 04/19/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: PSYCHIATRY | ||||||
| 04/08/2024 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $12.65 | General |
| Category: Bone Health | ||||||
| 04/03/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: NEUROSCIENCE | ||||||
| 03/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: NEUROSCIENCE | ||||||
| 03/13/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $12.83 | General |
| Category: Bone Health | ||||||
| 03/08/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: Diabetes | ||||||
| 03/01/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 833 | 1,493 | $156,404 | $50,871 |
| 2022 | 25 | 904 | 1,736 | $178,806 | $56,048 |
| 2021 | 27 | 1,103 | 2,241 | $223,431 | $70,082 |
| 2020 | 24 | 987 | 2,106 | $199,177 | $52,658 |
Total Patients
3,827
Total Services
7,576
Medicare Billing
$229,659
Procedure Codes
101
All Medicare Procedures & Services
101 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 135 | 360 | $68,040 | $20,361 | 29.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 70 | 70 | $20,230 | $8,555 | 42.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 23 | 76 | $14,364 | $4,397 | 30.6% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 14 | 14 | $5,978 | $2,185 | 36.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 26 | 36 | $6,804 | $2,145 | 31.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 133 | 227 | $2,043 | $1,907 | 93.3% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 23 | 23 | $3,457 | $1,692 | 49.0% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 11 | 20 | $4,620 | $1,613 | 34.9% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 19 | 19 | $4,199 | $1,409 | 33.6% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 63 | 65 | $2,600 | $852.80 | 32.8% |
| 99315 | Nursing facility discharge day management, 30 minutes or less | Facility | 2023 | 12 | 12 | $2,268 | $739.44 | 32.6% |
| 99307 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | Office | 2023 | 20 | 38 | $4,408 | $729.12 | 16.5% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 41 | 41 | $1,763 | $712.99 | 40.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 23 | 23 | $1,403 | $652.74 | 46.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 53 | 76 | $1,824 | $578.36 | 31.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 33 | 57 | $1,653 | $542.64 | 32.8% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 11 | 13 | $2,370 | $476.78 | 20.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 13 | 49 | $3,114 | $426.00 | 13.7% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 29 | 42 | $1,092 | $348.18 | 31.9% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 52 | 94 | $940.00 | $292.34 | 31.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 18 | 18 | $1,314 | $182.41 | 13.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 11 | 120 | $1,920 | $73.07 | 3.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 170 | 446 | $84,294 | $25,735 | 30.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 61 | 61 | $17,629 | $7,468 | 42.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 29 | 108 | $20,412 | $5,648 | 27.7% |
About Dr. Melissa Dobbins, D.O
Dr. Melissa Dobbins, D.O is a Family Medicine healthcare provider based in Wakefield, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/23/2009. The National Provider Identifier (NPI) number assigned to this provider is 1083842686.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Melissa Dobbins, D.O has received a total of $2,909 in payments from pharmaceutical and medical device companies, with $403.79 received in 2024. These payments were reported across 223 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($2,909).
As a Medicare-enrolled provider, Dobbins has provided services to 3,827 Medicare beneficiaries, totaling 7,576 services with total Medicare billing of $229,659. Data is available for 4 years (2020–2023), covering 101 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Wakefield, NE
- Active Since 06/23/2009
- Last Updated 03/10/2017
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1083842686
Products in Payments
- EVENITY (Biological) $407.48
- VRAYLAR (Drug) $180.62
- Otezla (Drug) $179.36
- Aimovig (Biological) $155.08
- Prolia (Biological) $136.02
- UBRELVY (Drug) $124.26
- Ozempic (Drug) $117.79
- DALVANCE (Drug) $96.45
- ELIQUIS (Drug) $88.28
- ENTRESTO (Drug) $78.77
- NURTEC ODT (Drug) $73.85
- INJECTAFER (Drug) $73.78
- QULIPTA (Drug) $64.63
- GARDASIL 9 (Biological) $56.47
- MOUNJARO (Drug) $54.74
- JARDIANCE (Drug) $54.20
- MATRIXRIB (Device) $46.47
- Veozah (Drug) $44.03
- TRADJENTA (Drug) $42.99
- Victoza (Drug) $41.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Wakefield
Dr. Jamiel Ambrad, Md, MD
Family Medicine — Payments: $18,655
Family Medicine $18,655
Benjamin Calef, M.d, M.D
Family Medicine — Payments: $5,286
Family Medicine $5,286
David Tomlinson, Md, MD
Family Medicine — Payments: $5,200
Family Medicine $5,200
Dr. David Calef, Md, MD
Family Medicine — Payments: $3,736
Family Medicine $3,736
Charlotte Moriarty, Md, MD
Family Medicine — Payments: $3,387
Family Medicine $3,387
John Graydon Kidd, M.d, M.D
Family Medicine — Payments: $774.59
Family Medicine $774.59